Weiss Multi-Strategy Advisers’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-159,143	Closed	-$637K	–	713
2019 Q4	$637K	Buy	+159,143	New	+$747K	0.01%	527
2018 Q4	–	Sell	-20,109	Closed	-$339K	–	668
2018 Q3	$390K	Buy	20,109 +109	+0.5%	+$2.32K	0.01%	466
2018 Q2	$511K	Sell	20,000 -2,500	-11%	-$58.3K	0.01%	487
2018 Q1	$453K	Buy	22,500 +2,500	+13%	+$58.3K	0.01%	469
2017 Q4	$401K	Sell	20,000 -30,000	-60%	-$590K	0.01%	508
2017 Q3	$1.04M	Buy	50,000 +20,000	+67%	+$338K	0.04%	372
2017 Q2	$444K	Buy	30,000 +20,000	+200%	+$333K	0.02%	461
2017 Q1	$160K	Buy	+10,000	New	+$144K	0.01%	523

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Weiss Multi-Strategy Advisers's DPLO Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 159,143 shares — an estimated $637K sold.

Weiss Multi-Strategy Advisers first reported a position in DPLO in Q1 2017 and held it in 8 quarters. The position peaked at $1.04M in Q3 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Weiss Multi-Strategy Advisers reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 159,143 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $637K.
Weiss Multi-Strategy Advisers first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's DIPLOMAT PHARMACY, INC. position peaked at $1.04M in Q3 2017.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.